MAXHEALTH Share Price, Analysis & Fundamentals

Max Healthcare shows strong fundamental growth and analyst buy ratings, yet remains under pressure due to a bearish technical trend with RSI at 44.06.

The stock is currently in a bearish technical trend, trading below its 50-day and 200-day moving averages, with a negative trend alignment score of -3. Momentum is also weak, as indicated by an RSI of 44.06 and a bearish MACD signal, suggesting that the price action is technically driven rather than influenced by specific company news today.
Despite the bearish technicals, the company's fundamentals show positive growth. In the latest quarter, revenue increased by 3.63% QoQ to ₹2,143 Cr, net profit rose by 13.62% QoQ to ₹342 Cr, and EPS grew by 13.92% QoQ to ₹3.52, indicating improving profitability.
Analyst sentiment remains predominantly positive, with 73.9% of analysts issuing 'Buy' or 'Strong Buy' ratings, a distribution that has been stable over the past month. This suggests confidence in the company's future prospects despite current technical weakness.
Institutional investors, holding 71.71% of the company's shares, showed a notable shift in the last quarter, with FIIs reducing their stake by 5.16% while DIIs increased theirs by 5.12%. This internal reallocation among institutions may warrant further monitoring.
The company released its earnings call transcript on May 29, 2026, providing further details on its financial performance and outlook. While no direct news impacts the stock today, this transcript offers insights into management's perspective on recent results and future strategies.
Recent news highlights are focused on sector-wide developments, including advancements in cancer detection technology within the healthcare sector and market outlooks for small-caps and pharma stocks for 2026. These are general industry trends and do not represent company-specific catalysts.

The stock experienced a positive 1-day return of 1.17%, but a negative 1-month return of -3.78%.
The trend is bearish, with the price below the 50-day and 200-day moving averages and a negative trend alignment score of -3.
Momentum is weak, indicated by an RSI of 44.06 and a bearish MACD signal.
Volatility is moderate with the price positioned at 29.08% of the Bollinger Band width, and a negative z-score of -0.837.
The stock is trading 24.94% below its 52-week high and 4.86% above its 52-week low, with a current drawdown of -24.94%.

The stock exhibits a bearish technical setup, characterized by prices trading below key EMAs and moving averages, and a negative trend alignment score. Momentum indicators like RSI and MACD are also signaling weakness. While volatility is present, the price is positioned within the lower half of the Bollinger Bands. Structurally, the stock is significantly off its 52-week high and has experienced a notable drawdown, indicating a prevailing downtrend.

Latest quarter revenue at ₹2,143 Cr, net profit at ₹342 Cr, and EPS at ₹3.52.
Quarter-over-quarter, revenue increased by 3.627%, net profit by 13.621%, and EPS by 13.916%.
Year-over-year, revenue grew by 12.199%, net profit by 7.21%, and EPS by 7.317%.
Profit before tax saw a significant QoQ increase of 27.397% and a YoY increase of 15.672%.

The company has released the transcript of its earnings call held on May 29, 2026, as per Regulation 30 of the LODR regulations. This document provides details discussed during the call.